Grant Theron

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

Grant Theron, Lynn S. Zijenah, Duncan Chanda et al. · The Lancet · 2013 · 444 citations

Public Health, Internal Medicine, Preventive Medicine +13

Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting

Grant Theron, Jonny Peter, Richard N. van Zyl-Smit et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 312 citations

Veterinary Medicine, Infectious Diseases, Microbiology +15

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

Jonny Peter, Lynn S. Zijenah, Duncan Chanda et al. · The Lancet · 2016 · 265 citations

Public Health, Infectious Disease Control, Clinical Medicine +10

The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges

Pren Naidoo, Grant Theron, Molebogeng X. Rangaka et al. · The Journal of Infectious Diseases · 2017 · 255 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?

Anil Pooran, Elize Pieterson, Malika Davids et al. · PLoS ONE · 2013 · 232 citations · Full text

Public Health, Infectious Disease Control, Pharmacoeconomics +17